Sunday, 25 April 2010

Troxérutine RPG




Troxérutine RPG may be available in the countries listed below.


Ingredient matches for Troxérutine RPG



Troxerutin

Troxerutin is reported as an ingredient of Troxérutine RPG in the following countries:


  • France

International Drug Name Search

Friday, 23 April 2010

Adizem




Adizem may be available in the countries listed below.


UK matches:

  • Adizem-SR capsules
  • Adizem-SR tablets
  • Adizem-XL capsules
  • Adizem-SR capsules (SPC)
  • Adizem-SR tablets (SPC)
  • Adizem-XL capsules (SPC)

Ingredient matches for Adizem



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Adizem in the following countries:


  • Bahrain

  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 21 April 2010

Oxytocin Stricker




Oxytocin Stricker may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oxytocin Stricker



Oxytocin

Oxytocin is reported as an ingredient of Oxytocin Stricker in the following countries:


  • Switzerland

International Drug Name Search

Sunday, 18 April 2010

Norgalax




Norgalax may be available in the countries listed below.


UK matches:

  • Norgalax Enema
  • Norgalax (SPC)

Ingredient matches for Norgalax



Docusate

Docusate Sodium is reported as an ingredient of Norgalax in the following countries:


  • Belgium

  • France

  • Germany

  • Ireland

  • Luxembourg

  • Netherlands

  • Singapore

  • Switzerland

  • Tunisia

  • United Kingdom

Glycerol

Glycerol is reported as an ingredient of Norgalax in the following countries:


  • Germany

  • Netherlands

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 15 April 2010

Ortho Evra


Ortho Evra is a brand name of ethinyl estradiol/norelgestromin, approved by the FDA in the following formulation(s):


ORTHO EVRA (ethinyl estradiol; norelgestromin - film, extended release; transdermal)



  • Manufacturer: JANSSEN PHARMS

    Approval date: November 20, 2001

    Strength(s): 0.02MG/24HR;0.15MG/24HR [RLD]

Has a generic version of Ortho Evra been approved?


No. There is currently no therapeutically equivalent version of Ortho Evra available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ortho Evra. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
    Patent 5,876,746
    Issued: March 2, 1999
    Inventor(s): Jona; Janan & Audett; Jay & Singh; Noel
    Assignee(s): Cygnus, Inc.
    Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women via an adhesive matrix of a silicone and/or polyisobutylene.
    Patent expiration dates:

    • November 20, 2015
      ✓ 
      Patent use: PREVENTION OF OVULATION IN A WOMAN
      ✓ 
      Drug product




  • Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
    Patent 5,972,377
    Issued: October 26, 1999
    Inventor(s): Jona; Janan & Audett; Jay & Singh; Noel
    Assignee(s): Cygnus, Inc.
    Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women.
    Patent expiration dates:

    • June 7, 2015
      ✓ 
      Patent use: PREVENTION OF OVULATION IN A WOMAN



See also...

  • Ortho Evra Consumer Information (Drugs.com)
  • Ortho Evra Patch Consumer Information (Wolters Kluwer)
  • Ortho Evra Consumer Information (Cerner Multum)
  • Ortho Evra Advanced Consumer Information (Micromedex)
  • Norelgestromin/Ethinyl Estradiol Patch Consumer Information (Wolters Kluwer)
  • Ethinyl estradiol and norelgestromin Consumer Information (Cerner Multum)
  • Ethinyl estradiol and norelgestromin Transdermal Advanced Consumer Information (Micromedex)

Tuesday, 13 April 2010

Lorazepam L.CH.




Lorazepam L.CH. may be available in the countries listed below.


Ingredient matches for Lorazepam L.CH.



Lorazepam

Lorazepam is reported as an ingredient of Lorazepam L.CH. in the following countries:


  • Chile

International Drug Name Search

Bactoscrub




Bactoscrub may be available in the countries listed below.


Ingredient matches for Bactoscrub



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Bactoscrub in the following countries:


  • Israel

International Drug Name Search

Wednesday, 7 April 2010

Decafen




Decafen may be available in the countries listed below.


Ingredient matches for Decafen



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Decafen in the following countries:


  • Bangladesh

International Drug Name Search

Monday, 5 April 2010

Inquixol




Inquixol may be available in the countries listed below.


Ingredient matches for Inquixol



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Inquixol in the following countries:


  • Venezuela

International Drug Name Search

Friday, 2 April 2010

Metronidazol La Santé




Metronidazol La Santé may be available in the countries listed below.


Ingredient matches for Metronidazol La Santé



Metronidazole

Metronidazole is reported as an ingredient of Metronidazol La Santé in the following countries:


  • Colombia

International Drug Name Search

Thursday, 1 April 2010

Amadin




Amadin may be available in the countries listed below.


Ingredient matches for Amadin



Glimepiride

Glimepiride is reported as an ingredient of Amadin in the following countries:


  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

International Drug Name Search